2[2]Sobel JD.Pathogenesis and treatment of recurrent vulvovaginal candidiasis.Clin Infect Dis,1992,14:S148-153.
3[3]Abu-Eltecn KH.Increased incidence of vulvovaginal candidiasis caused by candida glabrata in Jordan.Jpn J Infect Dis,2001,54:103-107.
4[4]Rocha CRC,Schroppel K,Harcus D,et al.Signaling through adenylyl cyclase is essential for hyphal growth and virulence in the pathogentic fungns candida albicans.Mol cell boil,2001,12:3631-3643.
5[7]Schaller M,Bein M,Korting HC,et al.The secreted aspartyl proteinases Sap1 and Sap2 cause tissue darage in an in vitro model of vaginal candidiasis based on reconsitituted human vaginal epithelium.Infect Immun,2003,71:3227-3234.
6[8]Fidel PL Jr,Sober JD.The role of cell-mediated immunity in candidiasis.Trands Microbiol,1994,2:202-206.
7[9]Wormley FL Jr,Cutright J,Fldel PL Jr.Multiple experimental designs to evaluate the role of T cell-mediated immunity against experimental vaginal candida albicans infection.Med Mycol,2003,41:401-409.
8[10]Carvalho LP,Bacellar O,Neves N,et al.Downregulatiun of IFN-γproduction in patients with recurrent vaginal candidiasis.J Allergy Clin Immunol,2002,109:102-105.
9[11]Pellis V,De Seta F,Crovella S,et al.Mannose-binding lectin and C3 act as recognition molecules for infectious agents in the vagina.Clin Exp Immunol,2005,139:120-126.
10[12]Neth O,Jack DL,Dodds AW,et al.Mannose-binding lectin binds to a range of clinically relevant microorganisms and promotes complement diposition.Infect immune,2000,68:688-693.
